Polar Capital Holdings Plc reduced its stake in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 0.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,003,747 shares of the biopharmaceutical company’s stock after selling 18,324 shares during […]